Intriguingly, LRBA deficiency and CTLA4 haploinsufficiency could represent human in vivo models of CTLA4 blockade with checkpoint inhibitors; medicines that actually improved survival in several cancers, particularly in melanoma, but also in gastric cancer [39, 40]. Here, LRBA is linked to gastric cancer.